The data shown below were compiled from readership statistics for 24 Mendeley readers of this research output. Click here to see the associated Mendeley record.
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
Mendeley readers
| Title |
Profile of users of drugs for the treatment of chronic hepatitis B available through the Brazilian Public Health System
|
|---|---|
| Published in |
Brazilian Journal of Infectious Diseases, July 2012
|
| DOI | 10.1016/j.bjid.2012.06.005 |
| Pubmed ID | |
| Authors |
Astrid Wiens, Luana Lenzi, Mônica Cavichiolo Grochocki, Cassyano Januário Correr, Roberto Pontarolo |
| Abstract |
Treatment for chronic hepatitis B in Brazil are funded by the Ministry of Health and by the state Departments of Health. Clinical protocol and therapeutic guidelines approve the use of adefovir, entecavir, interferon-α, lamivudine, and tenofovir for the treatment of chronic hepatitis B. The aim of this study was to establish the profile of users of these drugs in the state of Paraná. A cross-sectional study was conducted with patients under treatment in Paraná in August 2011. The following data were obtained: gender, hepatitis B used drug, International Classification of Diseases, and regional health unit. The monthly cost of these drugs for the public health system was also calculated. 1,093 patients registered were found, 70% male, and 2.6% co-infected with the delta agent. Tenofovir was the drug most commonly used (355 users). The highest prevalence was found in the regional health units of Pato Branco, Cascavel, Foz do Iguaçú, Francisco Beltrão, Toledo, Londrina, and Maringá. The annual cost for the public health system in Paraná was U$1,066,867. Through this study it was possible to investigate the distribution and profile of users of drugs for the treatment of chronic hepatitis B in Paraná in August 2011. |
Mendeley readers
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Brazil | 2 | 8% |
| United States | 1 | 4% |
| Unknown | 21 | 88% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Unspecified | 5 | 21% |
| Researcher | 5 | 21% |
| Student > Postgraduate | 3 | 13% |
| Student > Doctoral Student | 3 | 13% |
| Lecturer | 1 | 4% |
| Other | 6 | 25% |
| Unknown | 1 | 4% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 8 | 33% |
| Unspecified | 5 | 21% |
| Pharmacology, Toxicology and Pharmaceutical Science | 3 | 13% |
| Agricultural and Biological Sciences | 2 | 8% |
| Earth and Planetary Sciences | 2 | 8% |
| Other | 2 | 8% |
| Unknown | 2 | 8% |